Literature DB >> 29028700

Victims or Culprits, B Cells May Serve as Markers for Mortality Risk and Targeted Therapy in Sepsis.

Zoltán Spolarics1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29028700      PMCID： PMC6810592          DOI： 10.1097/CCM.0000000000002670

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  14 in total

1.  Hospital-based acute care use in survivors of septic shock.

Authors:  Alexandra Ortego; David F Gaieski; Barry D Fuchs; Tiffanie Jones; Scott D Halpern; Dylan S Small; S Cham Sante; Byron Drumheller; Jason D Christie; Mark E Mikkelsen
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

Review 2.  Allelic exclusion of immunoglobulin genes: models and mechanisms.

Authors:  Christian Vettermann; Mark S Schlissel
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte.

Authors:  R S Hotchkiss; K C Chang; P E Swanson; K W Tinsley; J J Hui; P Klender; S Xanthoudakis; S Roy; C Black; E Grimm; R Aspiotis; Y Han; D W Nicholson; I E Karl
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

4.  Innate response activator B cells protect against microbial sepsis.

Authors:  Philipp J Rauch; Aleksey Chudnovskiy; Clinton S Robbins; Georg F Weber; Martin Etzrodt; Ingo Hilgendorf; Elizabeth Tiglao; Jose-Luiz Figueiredo; Yoshiko Iwamoto; Igor Theurl; Rostic Gorbatov; Michael T Waring; Adam T Chicoine; Majd Mouded; Mikael J Pittet; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Science       Date:  2012-01-12       Impact factor: 47.728

Review 5.  Dual surface immunoglobulin light-chain expression in B-cell lymphoproliferative disorders.

Authors:  Dongsheng Xu
Journal:  Arch Pathol Lab Med       Date:  2006-06       Impact factor: 5.534

6.  Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population.

Authors:  Angela Dispenzieri; Jerry A Katzmann; Robert A Kyle; Dirk R Larson; Terry M Therneau; Colin L Colby; Raynell J Clark; Graham P Mead; Shaji Kumar; L Joseph Melton; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

7.  Gamma-globulin levels in patients with community-acquired septic shock.

Authors:  Fabio Silvio Taccone; Patrick Stordeur; Daniel De Backer; Jacques Creteur; Jean-Louis Vincent
Journal:  Shock       Date:  2009-10       Impact factor: 3.454

Review 8.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

9.  B cells enhance early innate immune responses during bacterial sepsis.

Authors:  Kindra M Kelly-Scumpia; Philip O Scumpia; Jason S Weinstein; Matthew J Delano; Alex G Cuenca; Dina C Nacionales; James L Wynn; Pui Y Lee; Yutaro Kumagai; Philip A Efron; Shizuo Akira; Clive Wasserfall; Mark A Atkinson; Lyle L Moldawer
Journal:  J Exp Med       Date:  2011-07-11       Impact factor: 14.307

Review 10.  Role of circulating lymphocytes in patients with sepsis.

Authors:  Raul de Pablo; Jorge Monserrat; Alfredo Prieto; Melchor Alvarez-Mon
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.